Cite
HARVARD Citation
Sharifi, M. et al. (2020). Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies. Cancer. 126 (15), pp. 3400-3416. [Online].